InVivo Therapeutics Holdings Corporation
(NASDAQ : NVIV)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen Inc.
0.01%358.531.2%$822.90m
AMGNAmgen Inc.
-0.58%191.681.2%$548.86m
CELGCelgene Corporation
-0.18%85.631.2%$541.37m
GILDGilead Sciences, Inc.
0.57%77.560.9%$485.48m
SRPTSarepta Therapeutics, Inc.
-0.58%134.5616.6%$345.23m
VRTXVertex Pharmaceuticals Incorporated
-0.30%180.591.9%$321.12m
REGNRegeneron Pharmaceuticals, Inc.
0.06%366.182.6%$293.66m
ILMNIllumina, Inc.
0.69%309.393.5%$269.06m
BLUEBluebird Bio, Inc.
0.00%179.5515.7%$208.16m
NKTRNektar Therapeutics
1.75%48.725.6%$178.51m
ALXNAlexion Pharmaceuticals, Inc.
-0.39%135.122.0%$175.72m
FMIFoundation Medicine, Inc.
0.09%136.938.8%$160.93m
EXASExact Sciences Corporation
0.76%67.2525.4%$160.51m
EXELExelixis, Inc.
-0.09%21.316.4%$135.64m
AAgilent Technologies, Inc.
1.95%64.221.5%$132.81m

Company Profile

Invivo Therapeutics Holdings Corp. operates as a research and clinical-stage biotechnology company, which engages in developing and commercializing biopolymer scaffolding devices for the treatment of SCIs. Its clinical development program is the Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. The company was founded by Joseph P. Vacanti, Frank M. Reynolds, and Robert Langer in 2005 and is headquartered in Cambridge, MA.